Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
question on HCP targeted communication on LinkedIn
-
We are reaching out in regards to guiding principles regarding communication with HCP via LinkedIn. Specifically, can we communicate about Brand Rx? In the PAAB FAQs we located information more in line with a DTC (question 458) but could not locate any information regarding targeted HCP.
We are looking to understand how you consider the qualification of HCP targeted only on LinkedIn in such a way that we can communicate about Rx brands (branded) with this audience the same way we can with reps, print or digital HCP media or via PTM